MAHAVIR ADVANCED REMEDIES LIMITED

(Formerly: Indo-American Advanced Pharmaceuticals Ltd.)

Regd. Office : No.91, D-11, Govindappa Naicken Street, Chennai 600 001
CIN - L24231TN1992PLC022562, Email : indoamerican1234@gmail.com, Wesbite : www.iaap.in
Rs. in Lacs
Statement of Unaudited Financial Results for the Quarter & Six Months ended 30th September 2014

Particulars
Sr.
No.
1 Income from Operations
a) Net Sales/Income/(Loss) from Investing Activities
b) Other Operating Income
Total Income from Operations (Net)
2 Expenses
(a) Cost of Material Consumed
(b) Purchases of Stock-in-trade

3 Months
ended
30.09.2014
Un-Audited
12.53
12.53
-

(c) Changes in Inventories of Finished Goods, Work-in-Progress and Stock-inTrade

3
4
5
6
7
8
9
10
11
12
13
14
15

Un-Audited
2.42
2.42
-

Un-Audited
2.62
2.62
-

6 Months
ended
30.09.2014

Corresponding 6
Months ended
30.09.2013

Year to date
figures as on
31.03.2014

Un-Audited

Un-Audited

Audited

14.95
14.95
-

5.12
5.12

10.29
10.29

(d) Employees Benefit Expenses

(e) Depreciation & Amortization Expenses
(f) Loss on Sale of Fixed Assets
(g) Other Expenses
Total Expenses
Profit/(Loss) from Operations before other Income, finance cost and
exceptional Expenses (1-2)
Other Income/(Loss)

0.36
1.34
1.70

0.36
1.24
1.60

0.30
0.44
0.74

0.72
2.58
3.30

0.60
1.48
2.08

6.60
11.63
18.23

10.83
-

0.82
-

1.88
-

11.65
-

3.04
-

(7.95)
21.72

Profit/(Loss) from ordinary activities before finance costs and

exceptional items (3+4)
Finance Costs

10.83
-

0.82
-

1.88
-

11.65
-

3.04
-

13.77
-

10.83
10.83
10.83
10.83
-

0.82
0.82
0.82
0.82
-

1.88
4.07
(2.19)
(2.19)
(2.19)
-

11.65
11.65
11.65
11.65
-

3.04
4.07
(1.03)
(1.03)
(1.03)
-

13.77
13.77
13.77
13.77
-

10.83
1,135.92
-

0.82
1,135.92
-

(2.19)
1,135.92

11.65
1,135.92
-

(1.03)
1,135.92
-

0.10
0.10

0.01
0.01

(0.02)
(0.02)

0.10
0.10

(0.01)
(0.01)

0.12
0.12

0.10
0.10

0.01
0.01

(0.02)
(0.02)

0.10
0.10

(0.01)
(0.01)

0.12
0.12

11,249,550

11,249,550

10,438,800

10,438,800

10,438,800

11,249,550

99.03

99.03

91.90

91.90

91.90

99.03

Profit/(Loss) from ordinary activities after finance cost but before

exceptional items (3+4)
Exceptional Items
Profit(+)/Loss(-) from ordinary activites before Tax (7-8)
Tax Expenses
Net Profit (+)/Loss(-) from ordinary activites after tax (9-10)
Extra Ordinary Items (Net of Tax Expense of Rs.
Lac)
Net Profit (+)/Loss(-) for the period (11-12)
Share of Profit/(Loss) of Associates*
Minority Interest*

Net Profit (+)/Loss(-) after tax, minority interest and Share of Profit /
16 (Loss) of Associates (13-14-15)
17 Paid-up Equity Share Capital (Face Value of Rs. 10/- each)
18 Reserves excluding revaluation Reserves as per last Balance Sheet
Earning Per Share (before extra-ordinary items) of Rs. 10/- each (not
19 annualized)
(i) a) Basic
b) Diluted
Earning Per Share (after extra-ordinary items) of Rs. 10/- each (not
19 annualized)
(ii) a) Basic
b) Diluted
A PARTICULARS OF SHAREHOLDING
Public Shareholding
- Number of Shares
- Percentage of Share Holding
18 Promoter and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of Shares
- Percentage of Shares (as a % of the total Shareholding
of Promoter and Promoter Group
- Percentage of Shares (as a % of the total Share Capital of the Company
b) None-Encumbered
- Number of Shares
- Percentage of Shares (as a % of the total Shareholding
of Promoter and Promoter Group
- Percentage of Shares (as a % of the total Share Capital of the Company
B INVESTOR COMPLAINTS
Pending at the beginning of the Quarter
Received during the Quarter
Notes :
1.
2.
3.
4.

Preceding 3 Corresponding 3
Months ended Months ended
30.06.2014
30.09.2013

13.77
1,135.92
(256.74)

109,650
100.00

109,650
100.00

920,400
100.00

920,400
100.00

920,400
100.00

109,650
100.00

0.97

0.97

8.10

8.10

8.10

0.97

Nil
Nil

Disposed during the Quarter

Remaining Unresolved at the end of Quarter

Nil
Nil

Segmental Report for the Quarter as per AS-17 of ICAI is not applicable for the Quarter.
Above resultes were reviewed by Audit Committee taken on record in Board Meeting held on 14th November, 2014.
Provision for Taxation will be made at the end of the Financial Year.
The Statutory Auditors of the Company have carried out "Limited Review" of the above Financial Results.

Place : Chennai
Date : 14th November, 2014

For MAHAVIR ADVANCED REMEDIES LIMITED

S/dM. MURUGADAS RAO
Director

MAHAVIR ADVANCED REMEDIES LIMITED

(Formerly: Indo American Advanced Pharmaceuticals Ltd.)
Statement of Assets & Liabilities
Rs. in Lacs
Particulars

30th Sept. 2014

Un-Audited

As at
31st March 2014
Audited

EQUITY & LIABILITIES

1 Shareholders' Fund
(a) Share Capital
(b) Reserves and Surplus
(c) Money Received against Share Warrants
Sub-Total - Share Holders Fund
2 Share Capital Money (Pending Allotment
3 Minority Interest*
4 Non Current Liabilities
(a) Long Term Borrowings
(b) Deferred Tax Liabilities (Net)
(c) Other Long Term Liabilities
(d) Long Term Provisions
Sub-Total - Long Term Liabilities
5 Current Liabilities
(a) Short Term Borrowings
(b) Trade Payables
(c) Other Current Liabilities
(d) Short Term Provisions
Sub-Total - Current Liabilities
TOTAL EQUITY & LIABILITIES
ASSETS
B
1 Non-Current Assets
(a) Fixed Assets
(b) Goodwill on Consolidation*
(c) Non-Current Investments
(d) Deferred Tax Assets (Net)
(e) Long Term Loans & Advances
(f) Other Non-Current Assets
(e) Misc. Expenditure
Sub-Total - Non Current Assets
2 Current Assets
(a) Current Investments
(b) Inventories
(c) Trade Receivables
(d) Cash & Cash Equivalents
(e) Short Term Loans & Advances
(f) Other Current Assets
Sub-Total - Current Assets
TOTAL - ASSETS

1,135.92
(245.09)
890.83
-

0.90
0.90
891.73

1.81
845.27
44.65
891.73
891.73

1,135.92
(256.74)
879.18
0.90
0.90
880.08

49.70
785.73
44.65
880.08
880.08